Skip to main content

JUUL Gets Preliminary Court Approval Over Vape Suits

JUUL Gets Preliminary Court Approval Over Vape Suits

JUUL Gets Preliminary Court Approval Over Vape Suits

Introduction

As the business attempts to settle hundreds of cases, Juul Labs Inc obtained preliminary court approval of a $255 million deal, settling customer accusations that it falsely promoted e-cigarettes.

According to a court filing, the proposed class action settlement settling claims by users who claimed they overpaid for Juul's vaping devices was fair, reasonable, and appropriate.

The payment is part of Juul's wider global agreement to settle hundreds of claims filed by school districts, local governments, and individuals accusing the company of contributing to a juvenile vaping pandemic.

Last month, the corporation said that it had negotiated settlements with about 10,000 claimants in over 5,000 instances. It has not stated how much it would pay, but sources claim that the transaction is worth $1.7 billion.

The class action settlement resolves claims by customers who allege they would have spent less or not purchased the e-cigarettes at all if Juul had not minimised the devices' addictiveness and marketed to youths via social media ads and other ways. A request for comment from Juul was not returned.

Juul, which is owned in part by Marlboro manufacturer Altria Group Inc, agreed in September to pay $438.5 million to resolve charges from 34 U.S. states and territories that the firm targeted underage buyers and downplayed the hazards of its products.

The Food and Drug Administration temporarily banned Juul's e-cigarettes in June, but the rule was eventually reversed after an appeal.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!